Contact Holly Rockweiler
Title CEO


Madorra is creating the first hormone-free medical device to treat vaginal dryness for postmenopausal women. The device is simple and easy to use, so women can comfortably treat themselves at home. After only a few weeks of therapy, women will be empowered and enabled to reclaim their sexual wellness.

The Madorra treatment paradigm provides a device solution for vaginal dryness, which is a problem that has to-date only been adequately addressed by pharmaceuticals. Vaginal dryness results from a decrease in estrogen levels, like the natural decrease that occurs during menopause. Today’s best treatment options are drugs or creams that replace the lost estrogen in order to relieve symptoms. However, hormone replacement therapy is not an option for large market segments because of the associated health risks (e.g. risk of stroke, breast cancer, etc.). Currently there are no effective, non-hormonal treatment options; thus, many women are barely getting by with lubricants, or worse, are living without intimacy. Madorra’s patient-powered healthcare gives women a safe alternative and an improved quality of life.

Company News

Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device

DateSep 9, 2021
Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy.
Read More →

Madorra Captures First Prize at OEN’s 2017 Angel Oregon Showcase

DateApr 30, 2017
Medical device company Madorra was selected as the top winner of OEN’s Angel Oregon 2017 Investment Program, announced on Thursday, April 27 at OEN’s Angel Oregon Showcase. Madorra received an investment of over $200,000.